EY015708/EY/NEI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2009	1
2010	4
2011	1
2012	2
2013	3
2014	1
2015	5
2016	2
2017	1
2018	1
2019	2
2020	2
2021	2
2022	5
2024	5

1

The Hippo Pathway in Liver Homeostasis and Pathophysiology.

Driskill JH, Pan D. Driskill JH, et al. Annu Rev Pathol. 2021 Jan 24;16:299-322. doi: 10.1146/annurev-pathol-030420-105050. Epub 2020 Nov 24. Annu Rev Pathol. 2021. PMID: 33234023 Free PMC article. Review.

2

The hippo signaling pathway in development and cancer.

Pan D. Pan D. Dev Cell. 2010 Oct 19;19(4):491-505. doi: 10.1016/j.devcel.2010.09.011. Dev Cell. 2010. PMID: 20951342 Free PMC article. Review.

3

The Hippo Signaling Pathway in Development and Disease.

Zheng Y, Pan D. Zheng Y, et al. Dev Cell. 2019 Aug 5;50(3):264-282. doi: 10.1016/j.devcel.2019.06.003. Dev Cell. 2019. PMID: 31386861 Free PMC article. Review.

4

YAP/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis.

Li H, Wu BK, Kanchwala M, Cai J, Wang L, Xing C, Zheng Y, Pan D. Li H, et al. Nat Cell Biol. 2022 Mar;24(3):373-383. doi: 10.1038/s41556-022-00848-5. Epub 2022 Feb 17. Nat Cell Biol. 2022. PMID: 35177822 Free PMC article.

5

Multiphase coalescence mediates Hippo pathway activation.

Wang L, Choi K, Su T, Li B, Wu X, Zhang R, Driskill JH, Li H, Lei H, Guo P, Chen EH, Zheng Y, Pan D. Wang L, et al. Cell. 2022 Nov 10;185(23):4376-4393.e18. doi: 10.1016/j.cell.2022.09.036. Epub 2022 Oct 31. Cell. 2022. PMID: 36318920 Free PMC article.

6

YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis.

Wu BK, Mei SC, Chen EH, Zheng Y, Pan D. Wu BK, et al. Nat Genet. 2022 Aug;54(8):1202-1213. doi: 10.1038/s41588-022-01119-7. Epub 2022 Jul 14. Nat Genet. 2022. PMID: 35835915 Free PMC article.

7

Elucidation of a universal size-control mechanism in Drosophila and mammals.

Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. Dong J, et al. Cell. 2007 Sep 21;130(6):1120-33. doi: 10.1016/j.cell.2007.07.019. Cell. 2007. PMID: 17889654 Free PMC article.

8

YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP.

Cai J, Choi K, Li H, Pulgar Prieto KD, Zheng Y, Pan D. Cai J, et al. Genes Dev. 2022 Nov-Dec 1;36(21-24):1119-1128. doi: 10.1101/gad.350127.122. Epub 2022 Dec 15. Genes Dev. 2022. PMID: 36522128 Free PMC article.

9

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.

Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D. Liu-Chittenden Y, et al. Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7. Genes Dev. 2012. PMID: 22677547 Free PMC article.

10

Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis.

Yang Y, Zhou H, Huang X, Wu C, Zheng K, Deng J, Zheng Y, Wang J, Chi X, Ma X, Pan H, Shen R, Pan D, Liu B. Yang Y, et al. Nat Commun. 2024 Jan 2;15(1):145. doi: 10.1038/s41467-023-44542-y. Nat Commun. 2024. PMID: 38168080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year